Serum IL-15 in patients with early systemic sclerosis: a potential novel marker of lung disease (Q36401844)

14 August 2017

Serum IL-15 in patients with early systemic sclerosis: a potential novel marker of lung disease (English)

1 reference

14 August 2017

Dirk M Wuttge

1

1 reference

14 August 2017

Marie Wildt

2

1 reference

14 August 2017

Pierre Geborek

3

1 reference

14 August 2017

Frank A Wollheim

4

1 reference

14 August 2017

Agneta Scheja

5

1 reference

14 August 2017

Anita Akesson

6

1 reference

14 August 2017

1 January 2007

1 reference

Arthritis Research and Therapy

14 August 2017

1 reference

14 August 2017

9

1 reference

14 August 2017

5

1 reference

14 August 2017

R85

1 reference

IL-15/IL-15 receptor biology: a guided tour through an expanding universe

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212554

Trans-presentation of donor-derived interleukin 15 is necessary for the rapid onset of acute graft-versus-host disease but not for graft-versus-tumor activity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212554

Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212554

Pathogenesis of Raynaud's phenomenon.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212554

Update on graft versus host disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212554

Targeting the interleukin-15/interleukin-15 receptor system in inflammatory autoimmune diseases

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212554

Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212554

Expression of interleukin-15 in mouse and human atherosclerotic lesions

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212554

Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212554

Macrovascular disease and systemic sclerosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212554

Death deflected: IL-15 inhibits TNF-alpha-mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL-15Ralpha chain

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212554

Interleukin 15 induces endothelial hyaluronan expression in vitro and promotes activated T cell extravasation through a CD44-dependent pathway in vivo

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212554

Capillary density in patients with systemic sclerosis, as determined by microscopy counts and compared with computer-based analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212554

Mortality and causes of death in a Swedish series of systemic sclerosis patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212554

Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212554

Predictors of end stage lung disease in systemic sclerosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212554

Serum interleukin-15 concentration in patients with essential hypertension.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212554

A cystatin C-based formula without anthropometric variables estimates glomerular filtration rate better than creatinine clearance using the Cockcroft-Gault formula.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212554

Interleukin-15 protects from lethal apoptosis in vivo.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212554

Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212554

Serum interleukin-15 is elevated in systemic lupus erythematosus

21 September 2018

1 reference

12 December 2020

Serum levels of interleukin 15 in patients with rheumatic diseases

1 reference

12 December 2020

Interleukin-15 inhibits spontaneous apoptosis in human eosinophils via autocrine production of granulocyte macrophage-colony stimulating factor and nuclear factor-kappaB activation

1 reference

12 December 2020

The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis

1 reference

12 December 2020

Plasma clearance of a new contrast agent, iohexol: a method for the assessment of glomerular filtration rate

1 reference

12 December 2020

Scleroderma (systemic sclerosis): classification, subsets and pathogenesis

1 reference

12 December 2020

Classification of systemic sclerosis (scleroderma): relationship of cutaneous subgroups in early disease to outcome and serologic reactivity

1 reference

12 December 2020

Sequential dermal microvascular and perivascular changes in the development of scleroderma

1 reference

12 December 2020

Autoantibody reactive with RNA polymerase III in systemic sclerosis

1 reference

12 December 2020

Macro- and microcirculatory effects of IL-15.

1 reference

12 December 2020

Mast cell accumulation and cytokine expression in the tight skin mouse model of scleroderma

1 reference

12 December 2020

In vitro release of interleukin-15 by broncho-alveolar lavage cells and peripheral blood mononuclear cells from patients with different lung diseases

1 reference

12 December 2020

Identifiers

DOI

10.1186/AR2284

1 reference

Dimensions Publication ID

14 August 2017

0 references

1 reference

14 August 2017

PubMed publication ID

17784951

1 reference